Treatment of Pediatric Mastoiditis with Penicillin Allergy
Initiate immediate intravenous broad-spectrum antibiotics with high-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component, maximum 4000 mg/day) as first-line therapy, but for penicillin-allergic patients, use intravenous ceftriaxone (50 mg/kg/day) or clindamycin (7 mg/kg per dose three times daily) combined with coverage for gram-negative organisms. 1, 2
Initial Management Algorithm
Immediate Actions Upon Diagnosis
Start IV antibiotics immediately upon clinical diagnosis of mastoiditis, which presents with retroauricular swelling, erythema, tenderness, and displacement of the pinna. 1, 2, 3
Perform myringotomy with or without tympanostomy tube insertion as part of initial management to drain middle ear fluid and obtain culture specimens. 1, 4
Initiate aggressive pain management with acetaminophen or ibuprofen immediately, as pain control is critical regardless of antibiotic therapy. 2
Antibiotic Selection for Penicillin Allergy
For patients with documented penicillin allergy:
First-generation cephalosporins (cephalexin 20 mg/kg per dose twice daily, maximum 500 mg per dose) can be used if the penicillin allergy is not severe (no history of anaphylaxis, angioedema, or urticaria). 5
Clindamycin (7 mg/kg per dose three times daily, maximum 300 mg per dose) is appropriate for severe penicillin allergy, though it lacks coverage for Haemophilus influenzae and Moraxella catarrhalis. 5, 2
Intramuscular ceftriaxone (50 mg/kg/day for 1-3 days, with 3-day course superior to 1-day) is highly effective for outpatient or initial management. 2, 4
Pathogen Coverage Considerations
The primary pathogens in pediatric mastoiditis are Streptococcus pneumoniae (28.57%), Staphylococcus aureus (16.32%), Streptococcus pyogenes, and Haemophilus influenzae. 3, 6
For complicated mastoiditis with suspected intracranial extension or severe disease:
Vancomycin plus one of the following: piperacillin-tazobactam, a carbapenem, ceftriaxone plus metronidazole, or a fluoroquinolone plus metronidazole. 1
Add clindamycin to penicillin therapy if Streptococcus pyogenes is confirmed, as this combination reduces toxin production. 1
Surgical Intervention Decision Points
Indications for Mastoidectomy
Proceed to mastoidectomy if:
Failure to improve after 48 hours of appropriate IV antibiotics. 1, 2
Development of subperiosteal abscess on clinical examination or imaging. 1, 2, 7
Presence of cholesteatoma identified on imaging. 2
Intracranial complications detected (brain abscess, sigmoid sinus thrombosis, meningitis). 1, 2
Clinical deterioration at any point during medical management. 1, 2
Conservative Management Success Rates
- Antibiotics alone: 10% success rate. 1
- Antibiotics plus myringotomy: 68% success rate. 1, 4
- Antibiotics plus mastoidectomy: 22% of cases require this approach. 1, 6
Approximately two-thirds (68%) of uncomplicated cases recover with conservative therapy consisting of wide myringotomy and IV antibiotics. 7
Imaging Protocol
When to Obtain CT Temporal Bone
Order CT temporal bone with IV contrast if:
Patient fails to improve after 48 hours of IV antibiotics. 1, 2
Suspicion of bony erosion, coalescence, or subperiosteal abscess based on clinical examination. 1, 8
CT provides high spatial resolution for assessing bony erosion and intratemporal complications. 2
When to Obtain MRI
Order MRI without and with IV contrast if:
- Intracranial complications are suspected (altered mental status, seizures, meningismus, neck rigidity, neurological deficits). 1, 2
MRI has higher sensitivity and specificity than CT for detecting brain abscess, subdural empyema, meningitis, or dural venous sinus thrombosis. 2
Duration and Transition of Therapy
IV Antibiotic Duration
Continue IV antibiotics for 7-10 days if mastoidectomy is performed. 2
For medical management alone, continue IV antibiotics until clinical improvement is noted (typically 4-10 days), then transition to oral antibiotics. 2, 4
Oral Antibiotic Transition
Once clinical improvement is documented:
Transition to oral antibiotics guided by culture results when available. 2
For penicillin-allergic patients, use oral cephalexin (20 mg/kg per dose twice daily) for non-severe allergies or clindamycin (7 mg/kg per dose three times daily) for severe allergies. 5
Total antibiotic duration (IV plus oral) should be 10-14 days for uncomplicated cases. 2, 8
Follow-Up and Monitoring
Short-Term Follow-Up
Daily visits during outpatient IV therapy by a combined team of otolaryngologist and pediatric infectious disease specialist are essential. 4
Monitor for complications: sigmoid sinus thrombosis, seizures, meningismus, neck rigidity, and neurological deficits. 2
Long-Term Follow-Up
Persistent middle ear effusion is common after resolution of acute symptoms and should be monitored. 2
Perform age-appropriate hearing testing if middle ear effusion persists for ≥3 months after resolution. 1, 2
Regular follow-up is essential to ensure complete resolution and monitor for potential complications or recurrence. 2
Critical Pitfalls and Caveats
Common Errors to Avoid
Prior antibiotic treatment does not prevent mastoiditis development: 33-81% of patients diagnosed with acute mastoiditis had received antibiotics before admission. 1, 2, 6
Do not delay imaging if clinical deterioration occurs: No reliable clinical signs distinguish patients with coexistent intracranial complications. 1, 2
Do not rely on mastoid radiographs for surgical decision-making; CT is the imaging modality of choice. 7
Negative cultures occur in 53.68% of cases, so empiric broad-spectrum coverage must be maintained until clinical improvement is documented. 6
Penicillin Allergy Management
Skin testing may be helpful in some patients to determine if true penicillin allergy persists, as only 10% of patients with reported penicillin allergy remain allergic over time. 5
Cephalosporins can be used cautiously in patients with non-severe penicillin allergies, as cross-reactivity is low (approximately 1-3%). 5
For severe penicillin allergy (history of anaphylaxis, angioedema, urticaria), avoid all beta-lactams and use clindamycin-based regimens. 5